Skip to main content
Log in

Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

A Correction to this article was published on 06 January 2021

This article has been updated

Abstract

Kin17 DNA and RNA binding protein (Kin17) is an extremely conserved nuclear protein that is almost expressed in every type of mammal cells. Recently, Kin17 has been implicated into the regulation of tumorigenesis of diverse human cancers. However, its functions in thyroid cancer (TC) are still largely unexplored. Kin17 mRNA and protein level were tested by qRT-PCR and western blot, respectively. Effects of Kin17 on TC cell proliferation were estimated by colony formation assay and flow cytometry analysis in vitro as well as by in vivo tumor growth experiment. TC cell migratory and invasive capacities were assessed via wound-healing and transwell experiments. Epithelial–mesenchymal transition (EMT)-related proteins (E-cadherin and N-cadherin) and p38 MAPAK signaling pathway-related proteins (p-p38, p38, Cyclin D1, and p27) were examined via western blot. Kin17 was remarkably increased in TC tissue samples and cell lines at both mRNA and protein levels compared to normal tissue and control cell line. Knockdown of Kin17 obviously repressed TC cell proliferation, arrested cell cycle, and inhibited TC cell migration and invasion in vitro, while overexpression of Kin17 produced opposite effects. Kin17 knockdown suppressed p38 MAPK signaling pathway, while Kin17 overexpression activated this pathway. Treatment of p38 agonist (p79350) abolished the repressive effects of sh-Kin17 on TC cell proliferation, migration, and invasion, as well as on p38 pathway. Kin17 knockdown was also found to enhance the sensitivity of Doxorubicin of TC cells. In addition, Kin17 knockdown in vivo also markedly repressed TC tumor growth and p38 pathway. Kin17 functioned as an oncogene of TC by activating p38 MAPK signaling pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Change history

Abbreviations

TC:

Thyroid cancer

FTC:

Follicular thyroid cancer

MTC:

Medullary thyroid carcinoma

PDTC:

Poorly differentiated thyroid cancer

ATC:

Anaplastic thyroid cancer

MAPK:

Mitogen-activated protein kinase

NSCLC:

Non-small cell lung cancer

References

  1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67:7–30. https://doi.org/10.3322/caac.21387

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34. https://doi.org/10.3322/caac.21551

    Article  PubMed  Google Scholar 

  3. Baloch ZW, LiVolsi VA (2018) Special types of thyroid carcinoma. Histopathology 72:40–52. https://doi.org/10.1111/his.13348

    Article  PubMed  Google Scholar 

  4. Azar FK, Lee SL, Rosen JE (2015) Medullary thyroid cancer: an update for surgeons. Am Surg 81:1–8

    Article  PubMed  Google Scholar 

  5. Massimino M, Evans DB, Podda M, Spinelli C, Collini P, Pizzi N, Bleyer A (2018) Thyroid cancer in adolescents and young adults. Pediatr Blood Cancer 65:e27025. https://doi.org/10.1002/pbc.27025

    Article  PubMed  Google Scholar 

  6. Roman BR, Morris LG, Davies L (2017) The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes 24:332–336. https://doi.org/10.1097/MED.0000000000000359

    Article  PubMed  PubMed Central  Google Scholar 

  7. Miccoli P, Bakkar S (2017) Surgical management of papillary thyroid carcinoma: an overview. Updates Surg 69:145–150. https://doi.org/10.1007/s13304-017-0449-5

    Article  PubMed  Google Scholar 

  8. Barbet J, Campion L, Kraeber-Bodere F, Chatal JF, Group GTES (2005) Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma. J Clin Endocrinol Metab 90:6077–6084. https://doi.org/10.1210/jc.2005-0044

    Article  CAS  PubMed  Google Scholar 

  9. Schmidbauer B, Menhart K, Hellwig D, Grosse J (2017) Differentiated thyroid cancer-treatment: state of the art. Int J Mol Sci. https://doi.org/10.3390/ijms18061292

    Article  PubMed  PubMed Central  Google Scholar 

  10. Cloutier P, Lavallee-Adam M, Faubert D, Blanchette M, Coulombe B (2014) Methylation of the DNA/RNA-binding protein Kin17 by METTL22 affects its association with chromatin. J Proteomics 100:115–124. https://doi.org/10.1016/j.jprot.2013.10.008

    Article  CAS  PubMed  Google Scholar 

  11. Tissier A, Kannouche P, Mauffrey P, Allemand I, Frelat G, Devoret R, Angulo JF (1996) Molecular cloning and characterization of the mouse Kin17 gene coding for a Zn-finger protein that preferentially recognizes bent DNA. Genomics 38:238–242. https://doi.org/10.1006/geno.1996.0623

    Article  CAS  PubMed  Google Scholar 

  12. Kannouche P, Mauffrey P, Pinon-Lataillade G, Mattei MG, Sarasin A, Daya-Grosjean L, Angulo JF (2000) Molecular cloning and characterization of the human KIN17 cDNA encoding a component of the UVC response that is conserved among metazoans. Carcinogenesis 21:1701–1710. https://doi.org/10.1093/carcin/21.9.1701

    Article  CAS  PubMed  Google Scholar 

  13. Miccoli L, Frouin I, Novac O, Di Paola D, Harper F, Zannis-Hadjopoulos M, Maga G, Biard DS, Angulo JF (2005) The human stress-activated protein kin17 belongs to the multiprotein DNA replication complex and associates in vivo with mammalian replication origins. Mol Cell Biol 25:3814–3830. https://doi.org/10.1128/MCB.25.9.3814-3830.2005

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Gao X, Liu Z, Zhong M, Wu K, Zhang Y, Wang H, Zeng T (2019) Knockdown of DNA/RNA-binding protein KIN17 promotes apoptosis of triple-negative breast cancer cells. Oncol Lett 17:288–293. https://doi.org/10.3892/ol.2018.9597

    Article  CAS  PubMed  Google Scholar 

  15. Zhang Y, Gao H, Gao X, Huang S, Wu K, Yu X, Yuan K, Zeng T (2017) Elevated expression of Kin17 in cervical cancer and its association with cancer cell proliferation and invasion. Int J Gynecol Cancer 27:628–633. https://doi.org/10.1097/IGC.0000000000000928

    Article  PubMed  Google Scholar 

  16. Kou WZ, Xu SL, Wang Y, Wang LW, Wang L, Chai XY, Hua QL (2014) Expression of Kin17 promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo. Oncol Lett 8:1190–1194. https://doi.org/10.3892/ol.2014.2244

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Zeng T, Gao H, Yu P, He H, Ouyang X, Deng L, Zhang Y (2011) Up-regulation of kin17 is essential for proliferation of breast cancer. PLoS ONE 6:e25343. https://doi.org/10.1371/journal.pone.0025343

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Cuenda A, Rousseau S (2007) p38 MAP-kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta 1773:1358–1375. https://doi.org/10.1016/j.bbamcr.2007.03.010

    Article  CAS  PubMed  Google Scholar 

  19. Cuadrado A, Nebreda AR (2010) Mechanisms and functions of p38 MAPK signalling. Biochem J 429:403–417. https://doi.org/10.1042/BJ20100323

    Article  CAS  PubMed  Google Scholar 

  20. Kim WG, Choi HJ, Kim TY, Shong YK, Kim WB (2014) The effect of 5-aminoimidazole-4-carboxamide-ribonucleoside was mediated by p38 mitogen activated protein kinase signaling pathway in FRO thyroid cancer cells. Korean J Intern Med 29:474–481. https://doi.org/10.3904/kjim.2014.29.4.474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Pomerance M, Quillard J, Chantoux F, Young J, Blondeau JP (2006) High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms. J Pathol 209:298–306. https://doi.org/10.1002/path.1975

    Article  CAS  PubMed  Google Scholar 

  22. Aschebrook-Kilfoy B, Schechter RB, Shih YC, Kaplan EL, Chiu BC, Angelos P, Grogan RH (2013) The clinical and economic burden of a sustained increase in thyroid cancer incidence. Cancer Epidemiol Biomark Prev 22:1252–1259. https://doi.org/10.1158/1055-9965.EPI-13-0242

    Article  Google Scholar 

  23. Zhang Y, Huang S, Gao H, Wu K, Ouyang X, Zhu Z, Yu X, Zeng T (2017) Upregulation of KIN17 is associated with non-small cell lung cancer invasiveness. Oncol Lett 13:2274–2280. https://doi.org/10.3892/ol.2017.5707

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ray A, Cleary MP (2017) The potential role of leptin in tumor invasion and metastasis. Cytokine Growth Factor Rev 38:80–97. https://doi.org/10.1016/j.cytogfr.2017.11.002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Grossi V, Peserico A, Tezil T, Simone C (2014) p38alpha MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol 20:9744–9758. https://doi.org/10.3748/wjg.v20.i29.9744

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gupta J, Nebreda AR (2015) Roles of p38alpha mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer. FEBS J 282:1841–1857. https://doi.org/10.1111/febs.13250

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Han SE, Park CH, Nam-Goong IS, Kim YI, Kim ES (2019) Anticancer effects of baicalein in FRO thyroid cancer cells through the up-regulation of ERK/p38 MAPK and Akt pathway. In Vivo 33:375–382. https://doi.org/10.21873/invivo.11484

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work is supported by the National Natural Science Foundation of China (No. 81660294) and The Youth Fund of Department of Education of Jiangxi Province (No. GJJ180146).

Author information

Authors and Affiliations

Authors

Contributions

Guarantor of integrity of the entire study: Y-XL; study concepts: Y-XL, Q-GJ; study design: Q-GJ; definition of intellectual content: C-FX; literature research: C-FX; clinical studies: Q-GJ; experimental studies: Y-XL, Q-GJ; data acquisition: Y-XL, Q-GJ; data analysis: C-FX; statistical analysis: Q-GJ; manuscript preparation: C-FX; manuscript editing: Q-GJ; manuscript review: Y-XL.

Corresponding author

Correspondence to Yun-Xia Lv.

Ethics declarations

Conflict of interest

The authors have no commercial or other associations that might pose a conflict of interest.

Ethical approval

Manipulates in this study were approved by the Ethics Committee of The First Affiliated Hospital of NanChang University, and written informed consent was provided to each participant. Human TC cell lines (K1, SW579, 8505C, TPC1, and BCPAP) and human thyroid follicular epithelial cells (Nthy-ori 3–1) were purchased from the American Type Culture Collection (ATCC, USA).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jiang, QG., Xiong, CF. & Lv, YX. Kin17 facilitates thyroid cancer cell proliferation, migration, and invasion by activating p38 MAPK signaling pathway. Mol Cell Biochem 476, 727–739 (2021). https://doi.org/10.1007/s11010-020-03939-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-020-03939-9

Keywords

Navigation